SARS-COV2 INFECTION

This study tested a new booster vaccine called PHH-1V81, designed to target recent COVID-19 variants. About 900 adults who had already received mRNA vaccines got either the new booster or an existing one. Researchers checked for side effects and measured immune responses to see i…

This study followed 92 people who had mild COVID and were treated at home. Two years after their diagnosis, they answered a questionnaire by mail about any hospital visits or other health events. The goal was to learn how outpatients fare over time and find patterns that could he…

This completed study tested whether phenelzine, a drug used for depression, could change how immune cells behave in people with COVID-19. Researchers took blood samples from 51 patients and exposed the cells to phenelzine in the lab. The goal was to see if the drug could reduce o…

This study looked at how many people in homeless shelters in Paris had COVID-19 antibodies after the first wave. Researchers tested 179 residents and staff from three shelters to measure past infections and deaths. The goal was to understand the virus's impact on a vulnerable pop…

This large observational study followed over 15,000 adults in the U.S. to learn more about long COVID (Post-Acute Sequelae of SARS-CoV-2 infection). Researchers tracked symptoms, health history, and biological samples over time in both infected and uninfected people. The goal is …